Fine launches new ‘cotton soft’ tissues

Hussein Al-Ghamdi, executive officer and chairman of the energy and manufacturing sector in the Saudi Quality Council Board, left, attended the press conference.
Updated 14 November 2017
0

Fine launches new ‘cotton soft’ tissues

Fine Hygienic Holding (FHH) — one of the world’s leading manufacturers of hygienic paper products — has for the first time infused its tissues with a touch of real cotton.
The company is promising individuals and families across the region a level of softness and comfort never before experienced by tissue consumers.
“While many tissue manufacturers will assert that their products are ‘cotton soft,’ Fine is now the first to actually deliver on this claim. A revolutionary innovation in terms of both quality and manufacturing, Fine’s new tissues are the softest and most soothing ever made — a true comfort to red, irritated noses everywhere,” Fine said in a press release.
The launch was announced at a recent press conference held in Jeddah, attended by Hussein Al-Ghamdi, executive officer and chairman of the energy and manufacturing sector in the Saudi Quality Council Board, and the senior management of Fine Holding.
“In any industry, there are leaders and there are followers,” said Fine Hygienic Holding CEO Salim Karadsheh. “Since the very beginning, we at Fine have worked tirelessly to lead the industry in every sense — from the quality of our products to our environmental impact, and beyond. This is especially true when it comes to innovating in our products and giving consumers exactly what they want. Infusing our tissues with the softness of cotton has been a challenge we have long been working on — and now, we’ve finally achieved this major milestone. This is such a momentous achievement for FHH, and we are eager to continue looking for new ways to delight our customers.”
With cold and flu season just around the corner, individuals everywhere are bracing themselves for the inevitable: congestion, sniffles, runny noses, and the redness and irritation that accompany these symptoms. Having to deal with the pain and discomfort of rough, abrasive tissues can make this germ- and virus-filled season even more exasperating. Fine said its soft, soothing tissues can help ease their discomfort.
Fine customers across the region can find the new tissues anywhere that the company’s products are sold.


New J-Clinic to harness machine learning tech

Updated 25 September 2018
0

New J-Clinic to harness machine learning tech

MIT and Community Jameel, the social enterprise organization founded and chaired by Mohammed Abdul Latif Jameel ‘78, launched the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic) on Tuesday. This is the fourth major collaborative effort between MIT and Community Jameel.
J-Clinic, a key part of the MIT Quest for Intelligence, will focus on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease. It will concentrate on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals, with three main areas of focus:
l Preventative medicine methods and technologies with the potential to change the course of non-infectious disease by stopping it in its tracks.
l Cost-effective diagnostic tests that may be able to both detect and alleviate health problems.
l Drug discovery and development to enable faster and cheaper discovery, development, and manufacture of new pharmaceuticals, particularly those targeted for individually customized therapies.
J-Clinic’s holistic approach will utilize MIT’s expertise in cellular and medical biology, computer science, engineering, and the social sciences, among other areas.
“The health care system has no shortage of data,” said MIT President L. Rafael Reif. “But it has far too little access to the kinds of tools and experts who can translate population-level data into clinical insights that could make it possible to tune care precisely for individuals. Building on MIT’s deep expertise in fields from cancer to neuroscience, and our longstanding connections to Boston’s world-class medical community, J-Clinic offers an accelerated path to creating new technologies that could help make health care more effective everywhere — from villages in developing nations to major teaching hospitals.”
“The J-Clinic will positively impact the world by accelerating the creation of machine learning technologies and algorithms that will make preventing, detecting, and treating disease more precise, affordable, and personalized,” said Anantha P. Chandrakasan, dean of the MIT School of Engineering, and Vannevar Bush, professor of electrical engineering and computer science, who will serve as J-Clinic’s chair. “It will be a truly multifaceted effort that amplifies synergies between the life sciences and the latest research in human and machine intelligence. J-Clinic will inspire innovation for the betterment of humanity.”
“Channeling MIT’s machine learning expertise into health care will transform medical outcomes for people around the world,” said Fady Jameel, president of Community Jameel International. “Health care has been an important sphere of activity for Community Jameel since our earliest days, from founding the first nonprofit hospital for physical rehabilitation in Saudi Arabia, to partnering with the King Salman Center for Disability Research. J-Clinic continues our journey of supporting cutting-edge research and driving innovation in health care, in Saudi Arabia and around the whole world.”